Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Mallik R, Chowdhury TA. Metformin in cancer. Diabetes Res Clin Pract. 2018;143:409–19.

Article  CAS  PubMed  Google Scholar 

Lai SW, et al. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan. Clin Lung Cancer. 2012;13(2):143–8.

Article  CAS  PubMed  Google Scholar 

Bragagnoli AC, et al. Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial. Br J Cancer. 2021;124(6):1072–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barakat HE, et al. The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial. Sci Rep. 2022;12(1):7656.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vancura A, et al. Metformin as an anticancer agent. Trends Pharmacol Sci. 2018;39(10):867–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apostolova N, et al. Mechanisms of action of metformin in type 2 diabetes: effects on mitochondria and leukocyte–endothelium interactions. Redox Biol. 2020;34:101517.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sekula P, et al. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol. 2016;27(11):3253–65.

Article  PubMed  PubMed Central  Google Scholar 

Tobin MD, et al. Commentary: development of Mendelian randomization: from hypothesis test to ‘Mendelian deconfounding.’ Int J Epidemiol. 2004;33(1):26–9.

Article  PubMed  Google Scholar 

Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ. 2005;330(7499):1076–9.

Article  PubMed  PubMed Central  Google Scholar 

Relton CL, Davey Smith G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012;41(1):161–76.

Article  PubMed  PubMed Central  Google Scholar 

Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734–9.

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

Article  PubMed  PubMed Central  Google Scholar 

Jones HJ, et al. Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study. Lancet Psychiatry. 2021;8(12):1062–70.

Article  PubMed  Google Scholar 

Verbanck M, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195–208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017;36(11):1783–802.

Article  PubMed  PubMed Central  Google Scholar 

Carter AR, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465–78.

Article  PubMed  PubMed Central  Google Scholar 

Yang BY, et al. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial. BJOG. 2020;127(7):848–57.

Article  PubMed  Google Scholar 

Skuli SJ, et al. Metformin and Cancer, an Ambiguanidous Relationship. Pharmaceuticals (Basel). 2022;15(5):1.

Article  Google Scholar 

Zheng Z, et al. Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis. Cell Cycle. 2020;19(10):1089–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YH, et al. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells. Mol Med Rep. 2021;23(1):1.

Google Scholar 

Haugrud AB, et al. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells. Breast Cancer Res Treat. 2014;147(3):539–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klose K, et al. Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line. PLoS ONE. 2021;16(9):e0257403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 2020;32(3):341–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wheaton WW, et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. Elife. 2014;3:e02242.

Article  PubMed  PubMed Central  Google Scholar 

Zoccali C, et al. Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis. 2006;47(2):332–41.

Article  PubMed  Google Scholar 

Zhou H, et al. Mendelian randomization study showed no causality between metformin use and lung cancer risk. Int J Epidemiol. 2020;49(4):1406–7.

Article  PubMed  Google Scholar 

Au Yeung SL, Schooling CM. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study. BMJ Open Diabetes Res Care. 2019;7(1):00872.

Article  Google Scholar 

Zhang Y, et al. Evaluating the impact of metformin targets on the risk of osteoarthritis: a Mendelian randomization study. Osteoarthr Cartil. 2022;30(11):1506–14.

Article  CAS  Google Scholar 

Yu L, et al. GDF-15 as a therapeutic target of diabetic complications increases the risk of gallstone disease: Mendelian randomization and polygenic risk score analysis. Front Genet. 2022;13:814457.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gierisch JM, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22(11):1931–43.

Article  PubMed  Google Scholar 

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159–68.

Article  PubMed Central  Google Scholar 

Kaaks R, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2005;97(10):755–65.

Article  CAS  PubMed  Google Scholar 

Micheli A, et al. Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol. 2007;25(19):2685–90.

Article  CAS  PubMed  Google Scholar 

Arthur RS, Dannenberg AJ, Rohan TE. The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank. Int J Cancer. 2021;149(1):42–57.

Article  CAS  PubMed  Google Scholar 

Watts EL, et al. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank. Int J Cancer. 2021;149(3):573–84.

Article  CAS  PubMed